Program
SHR8554
A development code. Also written as “SHR8554 Injection”, “SHR8554 Injection and SHR0410 Injection” and “SHR8554;Itraconazole”.
Its studies are mostly in Pain · Pain, Postoperative, led by Jiangsu HengRui Medicine.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Jiangsu HengRui Medicine | 60 open or running | phase 3since Feb 9, 2021 | Feb 9, 2021 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Feb 9, 2021First study: phase 3 study in PainFirst studyNCT04766463 · 528 enrolled · China
- Mar 9, 2021Phase 3 study in PainNCT04794738 · 192 enrolled · China
- May 11, 2022Phase 3 study in PainNCT05375305 · 320 enrolled · China
- Jul 20, 2022Phase 2 study in PainNCT05470049 · 108 enrolled
- Jun 26, 2023Phase 1 study in HealthyNCT05928988 · 17 enrolled · China
- Sep 17, 2025Phase 1 study in Moderate to Severe Postoperative PainNCT07189962 · 20 enrolled · China
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 6 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07189962Moderate to Severe Postoperative Pain · China | 1 | Completed | Apr 13, 2023 | 20 |
| NCT05928988Healthy · China | 1 | Completed | Jan 21, 2022 | 17 |
| NCT05470049Pain | 2 | UNKNOWN | Nov 1, 2022 | 108 |
| NCT05375305Pain · China | 3 | Completed | Oct 19, 2023 | 320 |
| NCT04794738Pain · China | 3 | UNKNOWN | Oct 30, 2021 | 192 |
| NCT04766463Pain · China | 3 | Completed | Oct 19, 2021 | 528 |
How it is read
Names in the registry
- “SHR8554 Injection”, 5 entries
- “SHR8554 Injection and SHR0410 Injection”, 2 entries
- “SHR8554”, 2 entries
- “SHR8554;Itraconazole”, 1 entry
Codes read as this program: SHR8554.
Conditions, from the studies’ own filings
- Pain, 4 studies
- Pain, Postoperative, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.